This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Rohatiner, A. Growth inhibitory effects of interferon on blast cells from patients with acute myelogenous leukaemia. Br J Cancer 49, 805–807 (1984). https://doi.org/10.1038/bjc.1984.125
Issue date:
DOI: https://doi.org/10.1038/bjc.1984.125
This article is cited by
-
Minimal residual disease-directed immunotherapy for high-risk myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation
Frontiers of Medicine (2019)
-
Interferon-α salvage treatment is effective for patients with acute leukemia/myelodysplastic syndrome with unsatisfactory response to minimal residual disease-directed donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation
Frontiers of Medicine (2019)
-
Interferon-α in acute myeloid leukemia: an old drug revisited
Leukemia (2011)
